XML 83 R67.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2020
Feb. 29, 2020
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share Price     $ 2.30 $ 1.25
Allocated Share-based Compensation Expense       $ 70,000
Shares available for issuance     44,405,107  
Number of award outstanding     2,501,419 1,893,201
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 1.84 $ 1.84
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period     4 years  
Allocated Share-based Compensation Expense       $ 4,000
Performance Shares        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share Based Compensation Arrangement By Share Based Payment Award Unrecognized Compensation Costs     $ 0  
Allocated Share-based Compensation Expense     $ 1,300,000  
Number of award outstanding     510,742  
Chief executive officer        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated Share-based Compensation Expense       153,000
Number of fully vested stock options issued   80,000    
Number of options to purchase common stock modified   236,970    
Chief executive officer | Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of awards whose vesting was accelerated   3,300    
Biostage Amended and Restated Equity Incentive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period     4 years  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period     10 years  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 3,000,000      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 5,098,000      
Share Price     $ 2.30  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value     $ 294,000  
Shares available for issuance     2,744,710  
Unrecognized compensation expense     $ 1,100,000  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition     1 year 9 months 29 days  
Biostage2013 Equity Incentive Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated Share-based Compensation Expense     $ 980,000 $ 1,144,000
Expected dividend yield     0.00% 0.00%